Indication and Treatment of Adult Kyphoscoliosis

NCT04536909 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-09-19

No results posted yet for this study

Summary

Degeneration, iatrogenic-/idiopathic causes and fractures can lead to kypho- scoliotic deformities potentially resulting in pain and loss of function. The surgical strategies rely on surgeon preferences and type of deformity as well as clinical symptoms. The complication rate of surgical treatment is high. The aim of this study is to elucidate the indications for surgical treatment of kyphoscoliosis and evaluate the effectiveness of surgical and non-surgical outcome clinically and radiologically.

The primary outcome for the PROMs and x-ray is at 12 months, but the investigators will also follow the patients with the PROMs and x-rays after 2,5 and 10 years.

Conditions

  • Kyphoscoliosis

Interventions

OTHER

Non-surgical

We have constructed a training program with help from physiotherapists from Rikshospitalet in Oslo, tailored for kyphotic- and scoliotic patients.

PROCEDURE

Surgical

Surgery for correction of kyphotic- or scoliotic deformity.

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER
  • Kyoto University Hospital

    collaborator OTHER
  • Region Örebro County

    collaborator OTHER
  • Skane University Hospital

    collaborator OTHER
  • Haukeland University Hospital

    collaborator OTHER
  • University of Bergen

    lead OTHER

Principal Investigators

  • Stephan M Rohrl, PhD · Oslo University Hospital Ullevåll

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2024-01-01
Completion
2026-01-01

Countries

  • Japan
  • Norway
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04536909 on ClinicalTrials.gov